Accountable officers to assess and investigate concerns
16.—(1) An accountable officer shall establish and operate, or ensure that his designated body establishes and operates, appropriate arrangements for—
(a)assessing concerns expressed about incidents that involved, or may have involved, the improper management or use of controlled drugs by a person who is, as regards his designated body, a relevant individual; and
(b)investigating such concerns.
(2) If, after an assessment of a concern expressed, the accountable officer decides that an investigation is needed, the accountable officer may—
(a)carry out that investigation himself;
(b)make a written request for another officer or employee of his designated body to carry out the investigation; or
(c)if appropriate, and subject to paragraph (5)—
(i)make a written request for an officer or employee (including, in the case of a designated body, an accountable officer) from any of the responsible bodies listed in paragraph (3) to carry out the investigation, or
(ii)make a written request for a number of officers or employees from any of the responsible bodies listed in paragraph (3) to form a joint investigation team to carry out the investigation.
(3) The following are responsible bodies for the purposes of section 18 of the 2006 Act and this regulation—
(a)a designated body;
(b)the Department;
(c)the Counter Fraud Unit of RBSO;
(d)the Police Service of Northern Ireland;
(e)RQIA;
(f)a regulatory body.
(4) An accountable officer may use his powers under paragraph (2)(c) to request an investigation (or a joint investigation with other responsible bodies) by the Counter Fraud Unit of RBSO into any possible fraud in relation to health care.
(5) The accountable officer shall keep, or ensure that his designated body keeps, a record of—
(a)any request made to an accountable officer from another designated body, or to another responsible body, under paragraph (2)(c) to investigate a concern that involved, or may have involved, the improper management or use of controlled drugs; and
(b)any assessment or investigation of a concern that involved, or may have involved, improper management or use of controlled drugs by a relevant individual that the accountable officer or his designated body carried out; and
(c)any notification given to another responsible body or accountable officer under regulation 25(4).